Could cytogenetics and minimal residual disease replace conventional risk criteria in adults with Ph-negative acute lymphoblastic leukaemia?

Br J Haematol. 2009 Mar;144(6):970-2. doi: 10.1111/j.1365-2141.2008.07540.x. Epub 2008 Dec 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Humans
  • Karyotyping
  • Middle Aged
  • Neoplasm, Residual / genetics
  • Neoplasm, Residual / pathology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Prognosis
  • Recurrence
  • Young Adult